Advertisement

A phase I trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Peter Martin, Nancy L. Bartlett, Kristie A. Blum, Steven Park, Kami Maddocks, Jia Ruan, LeAnn Ridling, Christopher Dittus, Zhengming Chen, Xiangao Huang, Giorgio Inghirami, Maurizio DiLiberto, Selina Chen-Kiang and John P. Leonard
This article has an Erratum 134(11):908

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted November 15, 2018
  • Accepted January 14, 2019
  • Published online January 28, 2019.

Article Versions


Contributors 
  • Peter Martin, 1 Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, United States;
  • Nancy L. Bartlett, 2 Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States;
  • Kristie A. Blum, 3 The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States;
  • Steven Park, 4 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States;
  • Kami Maddocks, 3 The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States;
  • Jia Ruan, 1 Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, United States;
  • LeAnn Ridling, 2 Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States;
  • Christopher Dittus, 4 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States;
  • Zhengming Chen, 5 Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, United States;
  • Xiangao Huang, 6 Meyer Cancer Center, Department of Pathology, Weill Cornell Medicine, New York, NY, United States
  • Giorgio Inghirami, 6 Meyer Cancer Center, Department of Pathology, Weill Cornell Medicine, New York, NY, United States
  • Maurizio DiLiberto, 6 Meyer Cancer Center, Department of Pathology, Weill Cornell Medicine, New York, NY, United States
  • Selina Chen-Kiang, 6 Meyer Cancer Center, Department of Pathology, Weill Cornell Medicine, New York, NY, United States
  • John P. Leonard, 1 Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output